L. Xu

发表

High expression reduces an antibody response after neonatal gene therapy with B domain‐deleted human factor VIII in mice

K. Ponder, X. Ma, M. Mei, 2007, Journal of thrombosis and haemostasis : JTH.

Generation of retroviral vector for clinical studies using transient transfection.

G. Nolan, G. Nabel, C. Barker, 1999, Human gene therapy.

Gene transfer in vivo with DNA-liposome complexes: lack of autoimmunity and gonadal localization.

E. Nabel, G. Nabel, Leaf Huang, 1992, Human gene therapy.

Growth factors and stromal support generate very efficient retroviral transduction of peripheral blood CD34+ cells from Gaucher patients.

R. Schiffmann, S. Karlsson, C. Dunbar, 1995, Blood.

Role of alpha beta T cells and gamma delta T cells in protective immunity to Actinobacillus actinomycetemcomitans in mutant mice by targeted gene disruption.

S. Hamada, I. Nakagawa, I. Takahashi, 1996, Journal of periodontal research.

Long-term in vivo expression of the human glucocerebrosidase gene in nonhuman primates after CD34+ hematopoietic cell transduction with cell-free retroviral vector preparations.

S. Karlsson, R. Brady, C. Dunbar, 1995, Proceedings of the National Academy of Sciences of the United States of America.

Correction of the enzyme deficiency in hematopoietic cells of Gaucher patients using a clinically acceptable retroviral supernatant transduction protocol.

R. Schiffmann, S. Karlsson, P. H. Correll, 1994, Experimental Hematology.

The transcriptional coactivator PGC1α protects against hyperthermic stress via cooperation with the heat shock factor HSF1

E. Mueller, A. Bagattin, L. Xu, 2016, Cell Death and Disease.

Poor transduction efficiency of human hematopoietic progenitor cells by a high-titer amphotropic retrovirus producer cell clone

S. Karlsson, H. Young, S. Kessler, 1994, Journal of virology.

Safety and short-term toxicity of a novel cationic lipid formulation for human gene therapy.

G. Nabel, P. Felgner, Leaf Huang, 1993, Human gene therapy.

Cell and viral regulatory elements enhance the expression and function of a human immunodeficiency virus inhibitory gene

D. Littman, G. Nabel, U. Ranga, 1997, Journal of virology.

Nonviral and viral delivery of a human immunodeficiency virus protective gene into primary human T cells.

M J Sheehy, Z. Yang, N. Yang, 1994, Proceedings of the National Academy of Sciences of the United States of America.

Bispecific Antibodies Targeting Different Epitopes on the HIV-1 Envelope Exhibit Broad and Potent Neutralization

W. Shi, J. Mascola, G. Chuang, 2015, Journal of Virology.

Gene transfer in vivo with DNA-liposome complexes: safety and acute toxicity in mice.

E. Nabel, G. Nabel, Leaf Huang, 1992, Human gene therapy.

Expression of a protective gene-prolongs survival of T cells in human immunodeficiency virus-infected patients.

G. Nabel, Z. Yang, G. Nabel, 1996, Proceedings of the National Academy of Sciences of the United States of America.

Expression of human glucocerebrosidase in murine macrophages: identification of efficient retroviral vectors.

S. Karlsson, D. Freas-Lutz, P. H. Correll, 1994, Experimental hematology.

Enhanced T cell engraftment after retroviral delivery of an antiviral gene in HIV-infected individuals.

G. Nabel, C. June, G. Nabel, 1998, Proceedings of the National Academy of Sciences of the United States of America.

Distinct cellular interactions of secreted and transmembrane Ebola virus glycoproteins.

A. Sanchez, G. Nabel, Ling Xu, 1998, Science.

CMV-beta-actin promoter directs higher expression from an adeno-associated viral vector in the liver than the cytomegalovirus or elongation factor 1 alpha promoter and results in therapeutic levels of human factor X in mice.

B. Byrne, T. Flotte, M. Sands, 2001, Human gene therapy.

S region transcription per se promotes basal IgE class switch recombination but additional factors regulate the efficiency of the process.

F. Alt, A. Bottaro, J. Zhang, 1994, The EMBO journal.

T cell vaccination induces T cell receptor Vbeta-specific Qa-1-restricted regulatory CD8(+) T cells.

L. Chess, N. Braunstein, Hong Jiang, 1998, Proceedings of the National Academy of Sciences of the United States of America.

Replacement of germ-line epsilon promoter by gene targeting alters control of immunoglobulin heavy chain class switching.

F. Alt, A. Bottaro, P. Rothman, 1993, Proceedings of the National Academy of Sciences of the United States of America.

DNA hypomethylation is crucial for apoptotic DNA to induce systemic lupus erythematosus-like autoimmune disease in SLE-non-susceptible mice.

S. Xiong, L Xu, Z K Wen, 2007, Rheumatology.

Gene transfer into human umbilical cord blood-derived CD34+ cells by particle-mediated gene transfer

D. Kohn, G. Nabel, U. Ranga, 1998, Gene Therapy.

Tumor-targeted p53-gene therapy enhances the efficacy of conventional chemo/radiotherapy.

E. Chang, K. Pirollo, L. Xu, 2001, Journal of controlled release : official journal of the Controlled Release Society.

Transferrin-liposome-mediated systemic p53 gene therapy in combination with radiation results in regression of human head and neck cancer xenografts.

E. Chang, A. Rait, K. Pirollo, 1999, Human gene therapy.

Production of anti-double-stranded DNA antibodies in activated lymphocyte derived DNA induced lupus model was dependent on CD4+ T cells

S. Xiong, Z. Wen, L. Xu, 2012, Lupus.

T cells + model was dependent on CD 4 Production of anti-double-stranded DNA antibodies in activated lymphocyte derived DNA induced lupus

S. Xiong, Z. Wen, L. Xu, 2012 .

Adeno-associated virus production of soluble tumor necrosis factor receptor neutralizes tumor necrosis factor alpha and reduces arthritis.

H. Hsu, Pingar Yang, J. Mountz, 2000, Human gene therapy.

Transferrin-liposome-mediated p53 sensitization of squamous cell carcinoma of the head and neck to radiation in vitro.

E. Chang, K. Pirollo, L. Xu, 1997, Human gene therapy.

Prevention and reversal of experimental autoimmune myasthenia gravis by a monoclonal antibody against acetylcholine receptor-specific T cells.

J. Blalock, M. Villain, S. Araga, 2001, Cellular immunology.